Haleos Labs Ltd

NSE:HALEOSLABSHealthcare

₹1,538.30+0.39%At closeAt close · Mon 19 Oct · ≈ AED 59.43 · Market cap $48.27M

INR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.1	0.0	0.0	0.0	0.0	0.0	+140.3%
Cash & short-term investments	0.1	0.0	0.0	0.0	0.0	0.0	+57.1%
Receivables	0.5	0.4	0.5	0.5	0.7	0.6	−11.4%
Inventory	0.7	0.8	0.9	0.8	0.7	0.8	+18.4%
Total current assets	1.3	1.6	1.6	1.6	1.5	1.6	+8.3%
Property, plant & equipment	1.6	2.0	2.3	2.3	2.4	2.8	+17.8%
Goodwill & intangibles	0.2	0.0	0.0	0.0	0.0	0.0	−45.2%
Long-term investments	0.0	0.0	0.0	0.0	0.0	0.0	+4.5%
Total assets	3.1	3.6	3.9	3.9	3.9	4.5	+16.5%
Payables	0.6	0.8	0.6	0.6	0.5	0.6	+15.3%
Short-term debt	0.3	0.4	0.4	0.6	0.7	0.6	−10.4%
Total current liabilities	1.1	1.4	1.3	1.5	1.4	1.6	+10.0%
Long-term debt	0.4	0.4	0.5	0.3	0.2	0.5	+173.5%
Total debt	0.7	0.8	1.0	1.0	0.9	1.1	+27.9%
Net debt	0.6	0.8	1.0	1.0	0.9	1.1	+27.3%
Deferred revenue	0.2	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	1.8	1.9	2.1	2.0	1.8	2.2	+26.4%
Total equity	1.3	1.5	1.7	1.8	2.0	2.1	+8.6%
Retained earnings	0.6	0.8	0.9	1.0	1.1	0.0	−100.0%

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.